Neuberger Berman Group »

Protagonist Therapeutics shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $8.6M 99k 87.34
2025-09-30 $8.2M 123k 66.43
2025-06-30 $5.2M 94k 55.27

More positions owned by Neuberger Berman Group

Microsoft Corp Common (MSFT)
Nvidia Corp Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Alphabet Inc Class A A Common (GOOGL)
Alphabet Inc-cl C Common (GOOG)
Jan28 Now P @ 120.000000 Option Put Option (NOW)
Jpmorgan Chase & Co Common (JPM)
Eli Lilly & Co Common (LLY)
February 26 Calls on HD US Option Call Option (HD)
Meta Platforms Inc Class A A Common (META)
Broadcom Common (AVGO)
Ishares Core S&p 500 Etf Etf (IVV)
Nextera Energy Common (NEE)
Visa Inc-class A Shares Common (V)

View all positions for Neuberger Berman Group

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Vanguard Group
Rtw Investments
State Street Corporation
UBS Group
BVF
Johnson & Johnson
Wellington Management Company
Invesco
Geode Capital Management
Woodline Partners
Driehaus Capital Management
Henderson Group
ADAR1 Capital Management

View all funds holding Protagonist Therapeutics